Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

186 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sensibility, specificity, and accuracy of the Sinonasal Outcome Test 8 (SNOT-8) in patients with chronic rhinosinusitis (CRS): a cross-sectional cohort study.
La Mantia I, Ragusa M, Grigaliute E, Cocuzza S, Radulesco T, Calvo-Henriquez C, Saibene AM, Riela PM, Lechien JR, Fakhry N, Michel J, Maniaci A. La Mantia I, et al. Among authors: cocuzza s. Eur Arch Otorhinolaryngol. 2023 Jul;280(7):3259-3264. doi: 10.1007/s00405-023-07855-8. Epub 2023 Jan 27. Eur Arch Otorhinolaryngol. 2023. PMID: 36705726
The submucosal approach influences long-term outcomes of refractory obstructive rhinitis: A prospective study and a STROBE analysis.
Maniaci A, Cocuzza S, Riela PM, Lechien JR, Calvo-Henriquez C, Saibene AM, Michel J, Radulesco T, Fakhry N, La Mantia I. Maniaci A, et al. Among authors: cocuzza s. Am J Otolaryngol. 2023 May-Jun;44(3):103808. doi: 10.1016/j.amjoto.2023.103808. Epub 2023 Mar 4. Am J Otolaryngol. 2023. PMID: 36905914 Free article. Clinical Trial.
Treatment of COVID-19 olfactory dysfunction with olfactory training, palmitoylethanolamide with luteolin, or combined therapy: a blinded controlled multicenter randomized trial.
Di Stadio A, Gallina S, Cocuzza S, De Luca P, Ingrassia A, Oliva S, Sireci F, Camaioni A, Ferreli F, Mercante G, Gaino F, Pace GM, La Mantia I, Brenner MJ. Di Stadio A, et al. Among authors: cocuzza s. Eur Arch Otorhinolaryngol. 2023 Nov;280(11):4949-4961. doi: 10.1007/s00405-023-08085-8. Epub 2023 Jun 28. Eur Arch Otorhinolaryngol. 2023. PMID: 37380908 Free PMC article. Clinical Trial.
Effectiveness and rapidity on olfatory fuction recovery in CRS patients treated with Dupilumab: a real life prospective controlled study.
La Mantia I, Grigaliute E, Ragusa M, Cocuzza S, Radulesco T, Saibene AM, Calvo-Henriquez C, Fakhry N, Michel J, Maniaci A. La Mantia I, et al. Among authors: cocuzza s. Eur Arch Otorhinolaryngol. 2024 Jan;281(1):219-226. doi: 10.1007/s00405-023-08184-6. Epub 2023 Aug 18. Eur Arch Otorhinolaryngol. 2024. PMID: 37594543
Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
Maniaci A, Saibene AM, Calvo-Henriquez C, Vaira L, Radulesco T, Michel J, Chiesa-Estomba C, Sowerby L, Lobo Duro D, Mayo-Yanez M, Maza-Solano J, Lechien JR, La Mantia I, Cocuzza S. Maniaci A, et al. Among authors: cocuzza s. Eur Arch Otorhinolaryngol. 2024 Apr;281(4):2167-2173. doi: 10.1007/s00405-024-08464-9. Epub 2024 Feb 8. Eur Arch Otorhinolaryngol. 2024. PMID: 38329526
186 results